A detailed history of Hrt Financial LP transactions in In8 Bio, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 11,252 shares of INAB stock, worth $2,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,252
Previous 10,813 4.06%
Holding current value
$2,813
Previous $9,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.27 - $0.88 $118 - $386
439 Added 4.06%
11,252 $3,000
Q2 2024

Aug 12, 2024

BUY
$0.85 - $1.68 $9,191 - $18,165
10,813 New
10,813 $9,000

Others Institutions Holding INAB

About IN8BIO, INC.


  • Ticker INAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,502,200
  • Market Cap $6.13M
  • Description
  • IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...
More about INAB
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.